Rein Therapeutics, Inc.
RNTXDrugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Q2 2027
Market Overview
Stock performance and key metrics
1 upcoming, 1 past
How RNTX's past catalysts played out
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Rein Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Rein Therapeutics, Inc.'s (RNTX) pipeline across Phase 2. Its lead program is LTI-03 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Rein Therapeutics, Inc.'s next FDA catalyst?→
Rein Therapeutics, Inc.'s (RNTX) next tracked catalyst is a Phase 2 expected May 28, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track RNTX biotech catalysts?→
Add RNTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Rein Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.